{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:53:50Z","timestamp":1790268830850,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000142","name":"Arthritis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007475","name":"Canadian Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006538","name":"Arthritis Society Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000033","name":"Institute of Musculoskeletal Health and Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clim.2023.109771","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T02:28:00Z","timestamp":1694485680000},"page":"109771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Architecture of skin inflammation in psoriasis revealed by spatial transcriptomics"],"prefix":"10.1016","volume":"256","author":[{"given":"Robert","family":"Gniadecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hennesey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Francis","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109771_bb0005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","article-title":"Psoriasis prevalence and severity by expert elicitation","volume":"11","author":"Papp","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.clim.2023.109771_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","article-title":"Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment","volume":"27","author":"Guttman-Yassky","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.clim.2023.109771_bb0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40257-016-0191-7","article-title":"Palmoplantar psoriasis and palmoplantar Pustulosis: current treatment and future prospects","volume":"17","author":"Raposo","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12589","article-title":"Underdiagnosed and undertreated psoriasis: nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails","volume":"31","author":"Merola","year":"2018","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.clim.2023.109771_bb0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/1346-8138.15089","article-title":"Relationship between the efficacy of biologics and clinical plaque psoriasis subtypes in Japanese patients: a single-center pilot study","volume":"46","author":"Ito","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40246-022-00431-x","article-title":"The integration of large-scale public data and network analysis uncovers molecular characteristics of psoriasis","volume":"16","author":"Federico","year":"2022","journal-title":"Hum. Genom."},{"key":"10.1016\/j.clim.2023.109771_bb0040","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1172\/JCI27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109771_bb0045","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"5","author":"Sbidian","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clim.2023.109771_bb0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2023.109771_bb0055","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","article-title":"Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon","volume":"9","author":"Mylonas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0060","doi-asserted-by":"crossref","first-page":"155897","DOI":"10.1016\/j.cyto.2022.155897","article-title":"Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions","volume":"156","author":"Sachen","year":"2022","journal-title":"Cytokine."},{"key":"10.1016\/j.clim.2023.109771_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2023.109771_bb0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/jdv.13132","article-title":"Comparison of three methods for measuring psoriasis severity in clinical studies (part 1 of 2): change during therapy in psoriasis area and severity index, static Physician\u2019s global assessment and lattice system Physician\u2019s global assessment","volume":"29","author":"Chow","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2023.109771_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6500","article-title":"Developmental cell programs are co-opted in inflammatory skin disease","volume":"371","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.clim.2023.109771_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn2263","article-title":"Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation","volume":"14","author":"Billi","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2023.109771_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1346-8138.14733","article-title":"Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization","volume":"46","author":"Kim","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.clim.2023.109771_bb0100","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","article-title":"S100 proteins as an important regulator of macrophage inflammation","volume":"8","author":"Xia","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0105","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109771_bb0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.clim.2023.109771_bb0115","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s10067-018-4138-7","article-title":"Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity","volume":"37","author":"Liu","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109771_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15 myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109771_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2353\/ajpath.2007.061067","article-title":"The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis","volume":"171","author":"Mee","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2023.109771_bb0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.isci.2019.10.008","article-title":"Skin Patterning in Psoriasis by Spatial Interactions between Pathogenic Cytokines","volume":"20","author":"Ringham","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.clim.2023.109771_bb0135","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","article-title":"IL-32, a novel cytokine with a possible role in disease","volume":"65 Suppl 3","author":"Dinarello","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109771_bb0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","article-title":"IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis","volume":"125","author":"Meyer","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0145","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/bjd.15458","article-title":"Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa","volume":"177","author":"Thomi","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2009.10.003","article-title":"Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta","volume":"49","author":"Hong","year":"2010","journal-title":"Cytokine."},{"key":"10.1016\/j.clim.2023.109771_bb0155","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3390\/v7062762","article-title":"Important role of the IL-32 inflammatory network in the host response against viral infection","volume":"7","author":"Zhou","year":"2015","journal-title":"Viruses."},{"key":"10.1016\/j.clim.2023.109771_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2023.109771_bb0165","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.clim.2023.109771_bb0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004030100240","article-title":"Expression of IL-18 in psoriasis","volume":"293","author":"Ohta","year":"2001","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2023.109771_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/JLB.3MR0620-550R","article-title":"Molecular interactions and functions of IL-32","volume":"109","author":"Aass","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2023.109771_bb0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0190","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/jid.2015.289","article-title":"Unprocessed interleukin-36\u03b1 regulates psoriasis-like skin inflammation in cooperation with Interleukin-1","volume":"135","author":"Milora","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2023.109771_bb0195","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109771_bb0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(00)00178-1","article-title":"c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin","volume":"103","author":"Szabowski","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.clim.2023.109771_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00535-022-01936-x","article-title":"Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease","volume":"58","author":"Andoh","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.clim.2023.109771_bb0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/1871530322666220113142533","article-title":"The emerging roles of IL-36, IL-37, and IL-38 in diabetes mellitus and its complications","volume":"22","author":"Huang","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.clim.2023.109771_bb0215","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism","volume":"102","author":"Netea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109771_bb0220","first-page":"73","article-title":"Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis","volume":"31","author":"Gui","year":"2013","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0225","doi-asserted-by":"crossref","first-page":"154832","DOI":"10.1016\/j.cyto.2019.154832","article-title":"Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-\u03b1 and IL-6","volume":"125","author":"Fadaei","year":"2020","journal-title":"Cytokine."},{"key":"10.1016\/j.clim.2023.109771_bb0230","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1159\/000525845","article-title":"The serum levels of IL-36 in patients with coronary artery disease and their correlation with the serum levels of IL-32, IL-6, TNF-\u03b1, and oxidative stress","volume":"183","author":"Kazemian","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0235","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.4049\/jimmunol.1003996","article-title":"IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production","volume":"186","author":"Jung","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109771_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2514","article-title":"An analysis of IL-36 signature genes and individuals with knockout mutations validates IL-36 as a psoriasis therapeutic target","volume":"9","author":"Mahil","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2023.109771_bb0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/JLB.4AB0219-071R","article-title":"IL-32 and its splice variants are associated with protection against mycobacterium tuberculosis infection and skewing of Th1\/Th17 cytokines","volume":"107","author":"Koeken","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2023.109771_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autrev.2006.08.015","article-title":"Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32)","volume":"6","author":"Conti","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109771_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","article-title":"Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas","volume":"38","author":"Moncada","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.clim.2023.109771_bb0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13059-021-02286-2","article-title":"Giotto: a toolbox for integrative analysis and visualization of spatial expression data","volume":"22","author":"Dries","year":"2021","journal-title":"Genome Biol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162300534X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162300534X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:10:51Z","timestamp":1761495051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162300534X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":52,"alternative-id":["S152166162300534X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109771","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Architecture of skin inflammation in psoriasis revealed by spatial transcriptomics","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109771"}}